Project Grant R01DK149276
Award Date 8/15/26
Completion Date 6/30/31
Dollars Obligated $756K
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Orange, CT 06477, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Brigham & Women's Hospital $891,382 on May 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a multisite evaluation of continuous glucose monitoring (CGM) effectiveness in older adults with type 2 diabetes. The recipient will assess how CGM-derived metrics influence clinician behavior and therapeutic decision-making, compare clinical outcomes and care...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation For The State University Of New York $799,752 on July 1, 2026, to conduct a randomized controlled trial comparing the efficacy of continuous glucose monitoring relative to traditional finger-stick self-monitoring of blood glucose in non-insulin-treated adults with poorly controlled type 2 diabetes. The study randomizes approximately 240 participants (≥8% of whom identify as African American) in a...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $839,770 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support cognitive and behavioral approaches to reduce binge eating and excess weight in adolescents. The award is a Project Grant with a period of performance extending through February 28, 2031, and work is performed in New Haven, Connecticut. The program promotes extramural basic...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $387,748 on April 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and evaluate a patient-centered collaborative care model for treating urinary incontinence in women with obesity and type 2 diabetes mellitus. The research addresses gaps in urinary incontinence care delivery. The project assesses patient preferences for obtaining urinary...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation For The State University Of New York $798,814 on August 1, 2026, for a randomized controlled trial testing continuous glucose monitoring combined with health coaching and values clarification in older adults with poorly controlled type 2 diabetes. The intervention targets 300 participants aged 65 and older with hemoglobin A1c of 9 percent or higher, randomized 1:1 to the intervention or...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $1,612,354 on September 13, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate pathogenic mechanisms linking intestinal microbial fermentation, adipose tissue metabolism, and cardiometabolic disease in obese youth with insulin resistance. The research will examine how insulin resistance impairs the protective metabolic responses triggered...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Scripps Health $331,277 on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to fund research integrating continuous glucose monitoring (CGM) in diabetes self-management education and support to improve glycemic control in Latino adults with type 2 diabetes. The research, titled "Integrating Continuous Glucose Monitoring in Diabetes Self-Management...
- The National Institute of Diabetes and Digestive and Kidney Diseases, a component of the Department of Health and Human Services National Institutes of Health, awarded $780,220 to Regents of the University of Michigan on February 27, 2026, under CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research) to conduct a clinical trial optimizing digital behavioral interventions for reducing severe hypoglycemia in adults with type 1 diabetes. The award funds a randomized...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Scripps Health $574,932 on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a randomized controlled trial evaluating the Enhancing Dulce Digital with CGM-Driven Personalization, Peer Support, Gamification, and Engagement (EDGE) intervention for type 2 diabetes self-management. The research will test EDGE's effectiveness in improving clinical and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Illinois $160,575 on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant K01DK147658). The award funds a three-year study of Medicaid alternative payment model (APM) implementation and evidence-based practice adoption in federally qualified health centers (FQHCs) to improve diabetes outcomes. The research addresses how FQHCs, which...